| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| LABP | Landos Biopharma, Inc. | Chief Executive Officer, Director | $0 | May 23, 2024 | ||
| ENTO | Entero Therapeutics, Inc. | Director | Jan 3, 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|